Nasdaq
APGE
Apogee Therapeutics, Inc.
- Health Care
- Listed 2023
- 1 day
- +0.2%
- 1 month
- +0.7%
- 1 year
- +270%
$134.49 · Mkt cap $10.1B
At the 6 Aug 2026 close
Nasdaq
Apogee Therapeutics, Inc.
$134.49 · Mkt cap $10.1B
At the 6 Aug 2026 close
Apogee Therapeutics, Inc. trades under the ticker APGE on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2023. Its market capitalisation is $10.1B. The last closing price was $134.49, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +270%, and +0.7% over the past month. Returns are price returns and exclude dividends.
This page exists because APGE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.